Recombinant von Willebrand Factor Prophylaxis for Severe von Willebrand Disease: Final Results Focusing on Adults Receiving Once Weekly Prophylaxis in a Phase 3b Continuation Study

Feb 6, 2026 — 09:33 am - 9:42 AM
The Auditorium

Main Session

Parent session

8:30 AM10:00 AM

Session 7: SLAM

Ruth GILMOREUniversity Hospital GalwayPratima CHOWDARY MAMILLAPALLI-